Evidence map›Paper›PMID 26817719›Full record

ReviewBioEssays : news and reviews in molecular, cellular and developmental biology2016

RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives.

Maciej Salaga, Martin Storr, Kirill A Martemyanov, Jakub Fichna

Abstract readReview
In one paragraph

Review in BioEssays : news and reviews in molecular, cellular and developmental biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Voltage-gated sodium channels: (NaThe Journal of physiology · 2018
    Review
  13. Article
  14. Tropical parasitology
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Maciej SalagaFaculty of Medicine, Department of Biochemistry, Medical University of Lodz, Lodz, Poland.
Martin StorrWalter Brendel Center of Experimental Medicine, University of Munich, Munich, Germany.
Kirill A MartemyanovDepartment of Neuroscience, The Scripps Research Institute, Jupiter, FL, USA.
Jakub FichnaFaculty of Medicine, Department of Biochemistry, Medical University of Lodz, Lodz, Poland.
Medical University of Lodz · PLCentre of Experimental Medicine of the Slovak Academy of Sciences · SKScripps Research Institute · US

Funding

Regulation of Striatal Signaling by RGS ProteinsR01DA036596 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Kirill A. Martemyanov · 2014 to 2026
$6.5M
Molecular Basis of RGS Protein Function in the StriatumK02DA026405 · NIDA · UNIVERSITY OF MINNESOTA · PI MARTEMYANOV, KIRILL A. · 2009 to 2019
$1.2M
NIDA NIH HHS DA026405NIDA NIH HHS DA036596NIDA NIH HHS K02 DA026405NIDA NIH HHS R01 DA036596
6 · The paper itself

Abstract

Regulators of G protein signaling (RGS) proteins provide timely termination of G protein-coupled receptor (GPCR) responses. Serving as a central control point in GPCR signaling cascades, RGS proteins are promising targets for drug development. In this review, we discuss the involvement of RGS proteins in the pathophysiology of the gastrointestinal inflammation and their potential to become a target for anti-inflammatory drugs. Specifically, we evaluate the emerging evidence for modulation of selected receptor families: opioid, cannabinoid and serotonin by RGS proteins. We discuss how the regulation of RGS protein level and activity may modulate immunological pathways involved in the development of intestinal inflammation. Finally, we propose that RGS proteins may serve as a prognostic factor for survival rate in colorectal cancer. The ideas introduced in this review set a novel conceptual framework for the utilization of RGS proteins in the treatment of gastrointestinal inflammation, a growing major concern worldwide.

Indexed as

AnalgesicsAnimalsAnti-Inflammatory Agents, Non-SteroidalColorectal NeoplasmsGastrointestinal MotilityGene Expression RegulationHumansInflammatory Bowel DiseasesIntestinesMiceReceptors, CannabinoidReceptors, OpioidReceptors, SerotoninRGS ProteinsSignal TransductionSmall Molecule LibrariesAnalgesicsAnti-Inflammatory Agents, Non-SteroidalReceptors, CannabinoidReceptors, OpioidReceptors, SerotoninRGS ProteinsSmall Molecule Librariesabdominal paincannabinoid receptorsgastrointestinal motilityGPCR signalinginflammatory bowel diseaseopioid receptorsRGS proteinsserotonin receptors

Identifiers

PMID26817719
PMCPMC4916644
OpenAlexW2321545831

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.